首页> 外文期刊>The Journal of respiratory diseases >Health care-associated pneumonia: Meeting the clinical challenges
【24h】

Health care-associated pneumonia: Meeting the clinical challenges

机译:卫生保健相关的肺炎:应对临床挑战

获取原文
获取原文并翻译 | 示例
           

摘要

The risk factors for health care-associated pneumonia (HCAP) include hospitalization for 2 or more days within the past 90 days, residence in a nursing home or extended-care facility, home infusion therapy, and long-term dialysis within the past 30 days. Distinguishing between community-acquired pneumonia (CAP) and HCAP is important because of the implications for therapy. Compared with CAP, HCAP is more likely to be caused by multidrug-resistant organisms and is associated with a higher mortality rate. The management of HCAP requires antimicrobial coverage of Pseudomonas aeru-ginosa, Acinetobacter species, extended-spectrum fi-lactamase-producing Enterobacteriaceae, and methicilHn-resistant Staph-ylococcus aureus. Empirical narrowing of therapy is probably safe in patients with culture-negative HCAP who have improved with broad-spectrum therapy.
机译:卫生保健相关性肺炎(HCAP)的风险因素包括过去90天内住院2天或以上,居住在疗养院或长期护理机构,家庭输液疗法以及过去30天内的长期透析。区分社区获得性肺炎(CAP)和HCAP很重要,因为它对治疗有影响。与CAP相比,HCAP更可能是由耐多药生物引起的,并且死亡率更高。 HCAP的管理要求对铜绿假单胞菌,不动杆菌属,产生广谱内酰胺酶的肠杆菌科细菌和耐甲氧西林金黄色葡萄球菌有抗菌作用。对于以培养阴性的HCAP患者,采用广谱治疗后,根据经验缩小治疗范围可能是安全的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号